Cellectis (CLLS) Non Operating Income (2015 - 2026)

Cellectis' (CLLS) quarterly Non Operating Income came in at -$7.4 million in Q1 2026, down 288.68% year-on-year from $3.9 million in Q1 2025, and down 143.52% quarter-over-quarter from $17.1 million in Q4 2025.

Cellectis (CLLS) Non Operating Income (2015 - 2026) Analysis & Trends

Cellectis' Non Operating Income history runs 12 years deep, the most recent figure standing at -$7.4 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 288.68% year-over-year to -$7.4 million in Q1 2026; TTM through Mar 2026 was -$11.9 million, a 2655.67% decrease from a year earlier, with the FY2025 full-year figure at -$34.9 million, down 253.29% from the prior year.
  • Non Operating Income eased to -$7.4 million in Q1 2026 per CLLS's latest filing, from $17.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $26.3 million in Q1 2024 and bottomed at -$26.1 million in Q4 2023.
  • The 5-year median for Non Operating Income is -$4.4 million (2023), against an average of -$1.7 million.
  • Across the five-year window, Non Operating Income sank 737.74% in 2022 and soared 696.89% in 2024, its largest moves.
  • Year by year, Non Operating Income stood at -$20.0 million in 2022, then tumbled by 30.87% to -$26.1 million in 2023, then soared by 165.54% to $17.1 million in 2024, then changed by 0.0% to $17.1 million in 2025, then sank by 143.52% to -$7.4 million in 2026.
  • Per Business Quant, the three latest CLLS Non Operating Income figures stand at -$7.4 million (Q1 2026), $17.1 million (Q4 2025), and -$7.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Cellectis 285.50 Mn 99.83 Mn - -7.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.45 Mn
Dec 31, 2025 17.12 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -14.15 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 17.12 Mn
Sep 30, 2024 -12.35 Mn
Jun 30, 2024 -8.25 Mn
Mar 31, 2024 26.28 Mn
Dec 31, 2023 -26.12 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 -5.84 Mn
Mar 31, 2023 -4.40 Mn
Dec 31, 2022 -19.96 Mn
Sep 30, 2022 1.81 Mn
Jun 30, 2022 8.30 Mn
Mar 31, 2022 -912,000.00
Dec 31, 2021 3.13 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 -4.13 Mn